AVANDIA - 55154-4518-4 - (rosiglitazone maleate)

Alphabetical Index


Drug Information of AVANDIA

Product NDC: 55154-4518
Proprietary Name: AVANDIA
Non Proprietary Name: rosiglitazone maleate
Active Ingredient(s): 8    mg/1 & nbsp;   rosiglitazone maleate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of AVANDIA

Product NDC: 55154-4518
Labeler Name: Cardinal Health
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021071
Marketing Category: NDA
Start Marketing Date: 19990528

Package Information of AVANDIA

Package NDC: 55154-4518-4
Package Description: 30 POUCH in 1 CARTON (55154-4518-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-4518-6)

NDC Information of AVANDIA

NDC Code 55154-4518-4
Proprietary Name AVANDIA
Package Description 30 POUCH in 1 CARTON (55154-4518-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-4518-6)
Product NDC 55154-4518
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name rosiglitazone maleate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 19990528
Marketing Category Name NDA
Labeler Name Cardinal Health
Substance Name ROSIGLITAZONE MALEATE
Strength Number 8
Strength Unit mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient]

Complete Information of AVANDIA


General Information